Scientists launch massive cancer biobank to unlock tumor secrets

NCT ID NCT03017573

Recruiting now Knowledge-focused Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects tumor and blood samples from over 1,000 people with certain cancers (ovarian, breast, head and neck, cervical, vulva, and sarcoma). Researchers will analyze the samples to find links between genetic changes, the immune system, and how the cancer behaves. Participants receive standard treatments; no experimental drugs are given. The goal is to improve future diagnosis and treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST ANGIOSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast angiosarcoma cervical cancer head and neck cancer Head and Neck Neoplasms ovarian cancer sarcoma triple-negative breast carcinoma Uterine Cervical Neoplasms uterine corpus sarcoma vulva cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HEAD AND NECK CANCER OVARIAN CANCER SARCOMA TRIPLE NEGATIVE BREAST CANCER VULVA CANCER

Contacts and locations

Locations

Centre Leon Berard
RECRUITING

Lyon, 69373, France
Centre Oscar Lambret
RECRUITING

Lille, 59000, France
Institut Bergonie
RECRUITING

Bordeaux, 33076, France
Institut Curie
RECRUITING

Paris, 75005, France
Institut Curie Hopital Rene Huguenin
RECRUITING

Saint-Cloud, 92210, France
Institut de Cancérologie de Lorraine - Nancy
NOT_YET_RECRUITING

Vandœuvre-lès-Nancy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.